Interstitial lung disease systemic sclerosis

Rossi G.A., Bitterman, P.B., Rennard, S.L, Ferrans, V.J. and Crystal, R.G. (1985). Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. Am. Rev. Respir. Dis. 131, 612-617. 

Steen VD, Lanz JK Jr., Conte C, et al. Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study. Arthritis Rheum 1994 37 1290-1296. 

Silver RM, Warrick JH, Kinsella MB, et al. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. J Rheumatol 1993 20 838-844. 

Dheda K, Lalloo UG, Cassim B, et al. Experience with azathioprine in systemic sclerosis associated with interstitial lung disease. Clin Rheumatol 2004 23 306-309. Moudgil A, Przygodzki RM, Kher KK. Successful steroid-sparing treatment of renal limited sarcoidosis with mycophenolate mofetil. Pediatr Nephrol 2006 21 281-285. 

Abbreviations-. ILA, interstitial lung disease RA, rheumatoid arthritis SLE, systemic lupus erythematosus SSc, systemic sclerosis DM, dermatomyositis PM, polymyositis SjS, Sjogren s syndrome MCTD, mixed connective tissue disease NSIP, non-specific interstitial pneumonia UIP, usual interstitial pneumonia OP, organizing pneumonia DAD, diffuse alveolar damage DIP, desquamative interstitial pneumonia LIP, lymphocytic interstitial pneumonia. 

Fischer A, Meehan RT, Feghali-Bostwick CA, et al. Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease. Chest 2006 ... 

Meloni F, Caporali R, Marone Bianco A, et al. Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease comparison with usual interstitial pneumonia. Ann Rheum Dis 2004 63 892-894. 

Beretta L, SantanieUo A, Lemos A, et al. Validity of the Saint George s Respiratory Questionnaire in the evaluation of the health-related quality of hfe in patients with interstitial lung disease secondary to systemic sclerosis. Rheumatology (Oxford) 2007 46 296-301. 

Launay D, Mouthon L, Hachulla E, et al. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. J Rheumatol 2007 34 1005-1011. 

Buch MH, Denton CP, Furst DE, et al. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis reproducibility and correlations of the 6-min walk test. Ann Rheum Dis 2007 66 169-173. 

Goh NS, Veeraraghavan S, Desai SR, et al. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression. Arthritis Rheum 2007 56 2005-2012. 

Takahashi H, Kuroki Y, Tanaka H, et al. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med 2000 162 258-263. 

Desai SR, Veeraraghavan S, Hansell DM, et al. CT features of lung disease in patients with systemic sclerosis comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004 232 560-567. 

---